CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $225,000 | -26.7% | 11,388 | -26.9% | 0.36% | -3.2% |
Q3 2021 | $307,000 | -75.0% | 15,586 | -66.8% | 0.37% | -76.1% |
Q4 2020 | $1,229,000 | +56.2% | 46,989 | +3.9% | 1.56% | +28.2% |
Q3 2020 | $787,000 | +38.6% | 45,233 | +34.1% | 1.22% | +48.3% |
Q2 2020 | $568,000 | +26.8% | 33,743 | -10.4% | 0.82% | +13.3% |
Q1 2020 | $448,000 | -4.1% | 37,646 | -2.5% | 0.72% | +74.5% |
Q4 2019 | $467,000 | +30.1% | 38,608 | +51.9% | 0.42% | +5.9% |
Q3 2019 | $359,000 | -17.8% | 25,409 | -35.2% | 0.39% | +72.7% |
Q2 2019 | $437,000 | -0.7% | 39,207 | +4.5% | 0.23% | -3.0% |
Q1 2019 | $440,000 | +2.1% | 37,519 | +16.2% | 0.23% | -12.0% |
Q4 2018 | $431,000 | -34.2% | 32,289 | -30.9% | 0.27% | -11.3% |
Q3 2018 | $655,000 | -27.1% | 46,727 | -18.3% | 0.30% | -22.1% |
Q2 2018 | $899,000 | -12.9% | 57,179 | -8.9% | 0.38% | +4.3% |
Q1 2018 | $1,032,000 | +5.5% | 62,746 | +15.9% | 0.37% | +11.1% |
Q4 2017 | $978,000 | +49.5% | 54,159 | +59.8% | 0.33% | +56.6% |
Q3 2017 | $654,000 | – | 33,891 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |